Martin Shkreli fined and banned from pharma for life
‘Pharma Bro’ must pay back $65m in profits for anticompetitive behaviour while leading Turing Pharmaceuticals
Martin Shkreli has been banned from working in the pharmaceutical industry for life. The former chief executive of Turing Pharmaceuticals (now known as Vyera Pharmaceuticals) has also been ordered to pay back almost $65 million (£48 million) in profits, in a competition lawsuit brought by the US Federal Trade Commission (FTC) and seven states.